Role of inositol 1,4,5-trisphosphate receptors in α1- adrenergic receptor-induced cardiomyocyte hypertrophy

Acta Pharmacologica Sinica

Volumn 27, Issue 7, 2006, Pages 895-900

  Luo, Da Li ^a,b   Gao, Jian ^a   Lan, Xiao Mei ^b   Wang, Gang ^c   Wei, Sheng ^c   Xiao, Rui Ping ^c   Han, Qi De ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c PEKING UNIVERSITY   (China)

Author keywords

1 adrenergic stimulation; Ca2+ sparks; Cardiac hypertrophy; Inositol 1,4,5 trisphosphate receptors

Indexed keywords

2 AMINOETHOXYDIPHENYLBORANE; ALPHA 1 ADRENERGIC RECEPTOR; ATRIAL NATRIURETIC FACTOR; ESTER DERIVATIVE; FLUORESCENT DYE; LEUCINE; MYOINOSITOL 1,4,5 TRIPHOSPHATE HEXAKIS(BUTYLRYLOXYMETHYL)ESTER; PHENYLEPHRINE; UNCLASSIFIED DRUG; XESTOSPONGIN C;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL LEVEL; CELL SIZE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; GENE EXPRESSION; HEART HYPERTROPHY; MEMBRANE PERMEABILITY; NONHUMAN; OSCILLATION; STEREOTYPY;

ANIMALS; ANIMALS, NEWBORN; ATRIAL NATRIURETIC FACTOR; BORON COMPOUNDS; CALCIUM; CALCIUM SIGNALING; CELLS, CULTURED; HEART VENTRICLES; HYPERTROPHY; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; LEUCINE; MACROCYCLIC COMPOUNDS; MYOCYTES, CARDIAC; OXAZOLES; PHENYLEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, ALPHA-1; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 33748521267     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00382.x     Document Type: Article

References (25)

1. Sugden PH, Clerk A. Cellular mechanisms of cardiac hypertrophy. J Mol Med 1998; 76: 725-46.
2. Yamamoto K, Dang QN, Maeda Y, Huang H, Kelly RA, Lee RT. Regulation of cardiomyocyte mechanotransduction by the cardiac cycle. Circulation 2001; 103: 1459-64.
3. 11 in cardiomyocytes. Nat Med 2001; 7: 1236-40.
4. q agonist pasteurella multocida toxin to promote cardiomyocyte hypertrophy and enhance apoptosis susceptibility. Circ Res 2002; 90: 850-7.
5. 2+, calcineurin, and NF-AT. Cell 1999; 96: 611-4.
6. Taigen T, De Windt LJ, Lim HW, Molkentin JD. Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci USA 2000; 97: 1196-201.
7. 2+-dependent gene expression mediated by MEF2 transcription factors. J Biol Chem 2000; 275: 197-209.
8. Akazawa H, Komuro I. Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 2003; 92: 1079-88.
9. 2+- dependent transgenic model of cardiac hypertrophy: a role for protein kinase Calpha. Circulation 2001; 103: 140-7.
10. 2-terminal kinase activation in the heart. Cross-talk between cardiac hypertrophic signaling pathways. J Biol Chem 2000; 275: 13571-9.
11. Marks AR. Cardiac intracellular calcium release channels-role in heart failure. Circ Res 2000; 87: 8-11.
12. Rosemblit N, Moschella MC, Ondriasa E, Gutstein DE, Ondrias K, Marks AR. Intracellular calcium release channel expression during embryogenesis. Dev Biol 1999; 206: 163-77.
13. Kolossov E, Fleischmann BK, Liu Q, Bloch W, Viatchenko-Karpinski S, Manzke O, et al, Functional characteristics of ES cell-derived cardiac precursor cells identified by tissue-specific expression of the green fluorescent protein. J Cell Biol 1998; 143: 2045-56.
14. Go LO, Moschella MC, Watras J, Handa KK, Fyfe BS, Marks AR. Differential regulation of two types of intracellular calcium release channels during end-stage heart failure. J Clin Invest 1995; 95: 888-94.
15. 2+ leak in heart failure. Circ Res 2005; 97: 1314-22.
16. Chesley A, Lundberg MS, Asai T, Xiao RP, Ohtani S, Lakatta EG, et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3′-kinase. Circ Res 2000; 87: 1172-9.
17. Li W, Schultz C, Llopis J, Tsien RY. Membrane-permeant esters of inositol polyphosphates, chemical syntheses and biological applications. Tetrahedron 1997; 53: 12017-40.
18. Venkatachalam K, van Rossum DB, Patterson RL, Ma HT, Gill DL. The cellular and molecular basis of store-operated calcium entry. Nat Rev Mol Cell Biol 2002; 4: 263-72.
19. Cheng H, Lederer WJ, Cannel MB. Calcium sparks: the elementary events underlying excitation-contraction coupling in heart muscle. Science 1993; 262: 740-4.
20. Wang Y, Huang S, Sah VP, Ross J Jr, Brown JH, Han J, et al. Cardiac muscle cell hypertrophy and apoptosis induced by distinct members of the p38 mitogen-activated protein kinase family. J Biol Chem 1998; 273: 2161-8.
21. Frey N, McKinsey TA, Olson EN. Decoding calcium signals involved in cardiac growth and function. Nat Med 2000; 6: 1221-7.
22. Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, et al. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998; 93: 215-28.
23. Bare DJ, Kettlun CS, Liang M, Ber DM, Mignery GA. Cardiac type 2 inositol 1,4,5-trisphosphate receptor: interaction and modulation by calcium/calmodulin-dependent protein kinase II. J Biol Chem 2005; 280: 15912-20.
24. Wu GY, Toyokawa T, Hahn H, Dorn GW. Epsilon protein kinase C in pathological myocardial hypertrophy. Analysis by combined transgenic expression of translocation modifiers and Galphaq. J Biol Chem 2000; 275: 29927-30.
25. Pan J, Fukuda K, Saito M, Matsuzaki J, Kodama H, Sano M, et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ Res 1999; 84: 1127-36.